UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002773
Receipt number R000003373
Scientific Title Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients
Date of disclosure of the study information 2009/11/17
Last modified on 2011/12/06 12:22:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Acronym

Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Scientific Title

Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Scientific Title:Acronym

Phase I study of extracts from Lentinula edodes mycelia in advanced cancer patients

Region

Japan


Condition

Condition

advanced cancer

Classification by specialty

Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Chest surgery Endocrine surgery Breast surgery
Obstetrics and Gynecology Oto-rhino-laryngology Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Assessment of safety of extracts from Lentinula edodes mycelia

Basic objectives2

Others

Basic objectives -Others

Assessment of immunoactivity
Assessment of quality of life

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

Safety

Key secondary outcomes

immunoactivity
quality of life


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

extracts from Lentinula edodes mycelia

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient with advanced cancer
No severe organ function impairment
Performance Status 0-1
Patient who is able to take oral medications
written informed consent of the patient

Key exclusion criteria

Pregnant female
Patient allergic to shiitake mushroom
Patient with ileus

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Ohno

Organization

Tokyo Women's Medical University

Division name

IREIIMS

Zip code


Address

8-1 Kawada-cho, Shinjuku-ku, Tokyo

TEL

03-3353-8111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Ohno

Organization

Tokyo Women's Medical University

Division name

IREIIMS

Zip code


Address


TEL

03-3353-8111

Homepage URL


Email

ohno@imcir.twmu.ac.jp


Sponsor or person

Institute

Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Kobayashi Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Bio-Thera Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2009 Year 11 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 11 Month 17 Day

Last modified on

2011 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003373


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name